VCYT
VERACYTE, INC.
+1.15 (+2.97%)39.65USD408K成交股數3.2B市值28.3本益比(近四季)5.7股價營收比+15.5%營收年增(近四季)2026-11-03下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 8 · 1.1M · 5 |
| 其中 10b5-1 計畫賣出 | 8 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 11.2M |
| 近 180 天 淨額 | −11.2M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 | 09-17 | Holstein Jens | Director | S 公開市場賣出(10b5-1) | 5.0K | 40.95 | 205K | 27.5K | SEC |
| 2026-09-04 | 09-04 | McGuire Annie | EVP, General Counsel | S 公開市場賣出(10b5-1) | 1.1K | 43.67 | 48K | 131K | SEC |
| 2026-09-04 | 09-04 | Chambers Rebecca | Chief Financial Officer | S 公開市場賣出(10b5-1) | 2.5K | 42.81 | 106K | 167K | SEC |
| 2026-09-04 | 09-04 | Febbo Phillip G. | Chief Scientific & Med Officer | S 公開市場賣出(10b5-1) | 10.4K | 42.89 | 446K | 136K | SEC |
| 2026-09-04 | 09-04 | Chambers Rebecca | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.2K | 43.71 | 51K | 166K | SEC |
| 2026-09-04 | 09-04 | Febbo Phillip G. | Chief Scientific & Med Officer | S 公開市場賣出(10b5-1) | 2.7K | 43.66 | 118K | 133K | SEC |
| 2026-09-04 | 09-04 | McGuire Annie | EVP, General Counsel | S 公開市場賣出(10b5-1) | 2.2K | 42.79 | 92K | 132K | SEC |
| 2026-09-02 | 09-04 | Chambers Rebecca | Chief Financial Officer | F 繳稅扣股 | 3.6K | 44.88 | 162K | 170K | SEC |
| 2026-09-02 | 09-04 | Leite John | Global Chief Commercial Off | F 繳稅扣股 | 4.0K | 44.88 | 178K | 128K | SEC |
| 2026-09-02 | 09-04 | McGuire Annie | EVP, General Counsel | F 繳稅扣股 | 3.2K | 44.88 | 144K | 134K | SEC |
| 2026-09-02 | 09-04 | Stapley Marc | Chief Executive Officer | F 繳稅扣股 | 8.8K | 44.88 | 394K | 432K | SEC |
| 2026-09-02 | 09-04 | Febbo Phillip G. | Chief Scientific & Med Officer | F 繳稅扣股 | 3.6K | 44.88 | 163K | 146K | SEC |
| 2026-09-02 | 09-04 | Wygant Jonathan | VP, Chief Accounting Officer | F 繳稅扣股 | 1.4K | 44.88 | 61K | 43.2K | SEC |
| 2026-09-01 | 09-03 | Bhanji Muna | Director | S 公開市場賣出(10b5-1) | 1.9K | 42.97 | 80K | 42.7K | SEC |
| 2026-06-18 | 06-22 | EASTHAM KARIN | Director | S 公開市場賣出(10b5-1) | 3.2K | 52.78 | 169K | 15.6K | SEC |
| 2026-06-18 | 06-22 | EASTHAM KARIN | Director | S 公開市場賣出(10b5-1) | 529 | 53.55 | 28K | 15.1K | SEC |
| 2026-06-11 | 06-15 | Miller Thomas F. | Director | A 獲配股票 | 5.3K | – | – | 31.1K | SEC |
| 2026-06-11 | 06-15 | Bhanji Muna | Director | A 獲配股票 | 5.3K | – | – | 44.6K | SEC |
| 2026-06-11 | 06-15 | JONES EVAN/ FA | Director | A 獲配股票 | 5.3K | – | – | 34.6K | SEC |
| 2026-06-11 | 06-15 | Shafer David Brent | Director | A 獲配股票 | 5.3K | – | – | 31.1K | SEC |
| 2026-06-11 | 06-15 | Holstein Jens | Director | A 獲配股票 | 5.3K | – | – | 32.5K | SEC |
| 2026-06-11 | 06-15 | Barr Eliav | Director | A 獲配股票 | 5.3K | – | – | 56.5K | SEC |
| 2026-06-11 | 06-15 | EASTHAM KARIN | Director | A 獲配股票 | 5.3K | – | – | 18.8K | SEC |
| 2026-06-11 | 06-15 | EPSTEIN ROBERT S | Director | A 獲配股票 | 5.3K | – | – | 57.7K | SEC |
| 2026-06-04 | 06-04 | Chambers Rebecca | Chief Financial Officer | S 公開市場賣出(10b5-1) | 1.6K | 49.28 | 79K | 175K | SEC |
| 2026-06-04 | 06-04 | Stapley Marc | Chief Executive Officer | M 選擇權執行 | 138K | 36.60 | 5.1M | 579K | SEC |
| 2026-06-04 | 06-04 | Stapley Marc | Chief Executive Officer | S 公開市場賣出(10b5-1) | 138K | 50.12 | 6.9M | 440K | SEC |
| 2026-06-04 | 06-04 | Leite John | Global Chief Commercial Off | S 公開市場賣出(10b5-1) | 14.0K | 50.07 | 700K | 132K | SEC |
| 2026-06-04 | 06-04 | McGuire Annie | EVP, General Counsel | S 公開市場賣出(10b5-1) | 1.8K | 50.12 | 89K | 137K | SEC |
| 2026-06-04 | 06-04 | Chambers Rebecca | Chief Financial Officer | S 公開市場賣出(10b5-1) | 2.0K | 50.09 | 98K | 173K | SEC |
| 2026-06-04 | 06-04 | McGuire Annie | EVP, General Counsel | S 公開市場賣出(10b5-1) | 1.4K | 49.31 | 69K | 139K | SEC |
| 2026-06-02 | 06-04 | Chambers Rebecca | Chief Financial Officer | F 繳稅扣股 | 3.7K | 47.80 | 177K | 177K | SEC |
| 2026-06-02 | 06-04 | Febbo Phillip G. | Chief Scientific & Med Officer | F 繳稅扣股 | 3.7K | 47.80 | 178K | 150K | SEC |
| 2026-06-02 | 06-04 | Wygant Jonathan | VP, Chief Accounting Officer | F 繳稅扣股 | 1.4K | 47.80 | 65K | 44.1K | SEC |
| 2026-06-02 | 06-04 | Leite John | Global Chief Commercial Off | F 繳稅扣股 | 4.1K | 47.80 | 194K | 146K | SEC |
| 2026-06-02 | 06-04 | McGuire Annie | EVP, General Counsel | F 繳稅扣股 | 3.3K | 47.80 | 157K | 140K | SEC |
| 2026-06-02 | 06-04 | Stapley Marc | Chief Executive Officer | F 繳稅扣股 | 9.0K | 47.80 | 431K | 440K | SEC |
| 2026-05-22 | 05-27 | Wygant Jonathan | VP, Chief Accounting Officer | M 選擇權執行 | 24.0K | 24.80 | 595K | 69.4K | SEC |
| 2026-05-22 | 05-27 | Wygant Jonathan | VP, Chief Accounting Officer | S 公開市場賣出 | 24.0K | 45.40 | 1.1M | 45.4K | SEC |
| 2026-05-20 | 05-22 | EPSTEIN ROBERT S | Director | S 公開市場賣出(10b5-1) | 10.0K | 44.01 | 440K | 52.4K | SEC |
| 2026-05-06 | 05-08 | McGuire Annie | SVP, General Counsel | S 公開市場賣出(10b5-1) | 5.1K | 38.05 | 194K | 149K | SEC |
| 2026-05-06 | 05-08 | McGuire Annie | SVP, General Counsel | S 公開市場賣出(10b5-1) | 5.1K | 40.00 | 204K | 144K | SEC |
| 2026-04-10 | 04-14 | Haas Kevin Richard | Chief Dev and Tech Officer | A 獲配股票 | 44.2K | – | – | 44.2K | SEC |
| 2026-03-06 | 03-10 | Chambers Rebecca | Chief Financial Officer | A 獲配股票 | 13.2K | – | – | 181K | SEC |
| 2026-03-06 | 03-10 | Leite John | Chief Commercial Officer-CLIA | A 獲配股票 | 6.6K | – | – | 150K | SEC |
| 2026-03-06 | 03-10 | Chambers Rebecca | Chief Financial Officer | A 獲配股票 | 36.2K | – | – | 167K | SEC |
| 2026-03-06 | 03-10 | McGuire Annie | SVP, General Counsel | A 獲配股票 | 26.3K | – | – | 154K | SEC |
| 2026-03-06 | 03-10 | McGuire Annie | SVP, General Counsel | A 獲配股票 | 32.9K | – | – | 128K | SEC |
| 2026-03-06 | 03-10 | Stapley Marc | Chief Executive Officer | A 獲配股票 | 92.1K | – | – | 450K | SEC |
| 2026-03-06 | 03-10 | Leite John | Chief Commercial Officer-CLIA | A 獲配股票 | 36.2K | – | – | 144K | SEC |
| 2026-03-06 | 03-10 | Febbo Phillip G. | Chief Scientific & Med Officer | A 獲配股票 | 6.6K | – | – | 154K | SEC |
| 2026-03-06 | 03-10 | Febbo Phillip G. | Chief Scientific & Med Officer | A 獲配股票 | 29.6K | – | – | 147K | SEC |
| 2026-03-06 | 03-10 | Wygant Jonathan | VP, Chief Accounting Officer | A 獲配股票 | 10.5K | – | – | 45.4K | SEC |
| 2026-03-04 | 03-06 | Stapley Marc | Chief Executive Officer | S 公開市場賣出(10b5-1) | 26.3K | 36.28 | 953K | 358K | SEC |
| 2026-03-04 | 03-06 | Leite John | Chief Commercial Officer-CLIA | S 公開市場賣出(10b5-1) | 5.3K | 35.19 | 185K | 108K | SEC |
| 2026-03-04 | 03-06 | Stapley Marc | Chief Executive Officer | S 公開市場賣出(10b5-1) | 19.2K | 35.56 | 684K | 384K | SEC |
| 2026-03-04 | 03-06 | McGuire Annie | SVP, General Counsel | S 公開市場賣出(10b5-1) | 1.7K | 36.34 | 60K | 94.7K | SEC |
| 2026-03-04 | 03-06 | McGuire Annie | SVP, General Counsel | S 公開市場賣出(10b5-1) | 5.0K | 35.29 | 176K | 96.4K | SEC |
| 2026-03-04 | 03-06 | Chambers Rebecca | Chief Financial Officer | S 公開市場賣出(10b5-1) | 13.9K | 36.33 | 506K | 131K | SEC |
| 2026-03-04 | 03-06 | Chambers Rebecca | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.4K | 35.55 | 156K | 145K | SEC |
| 2026-03-02 | 03-04 | Febbo Phillip G. | Chief Scientific & Med Officer | F 繳稅扣股 | 6.0K | 36.01 | 217K | 131K | SEC |
| 2026-03-02 | 03-04 | Wygant Jonathan | VP, Chief Accounting Officer | F 繳稅扣股 | 3.0K | 36.01 | 108K | 34.9K | SEC |
| 2026-03-02 | 03-04 | Chambers Rebecca | Chief Financial Officer | F 繳稅扣股 | 7.2K | 36.01 | 260K | 150K | SEC |
| 2026-03-02 | 03-04 | Febbo Phillip G. | Chief Scientific & Med Officer | S 公開市場賣出(10b5-1) | 13.4K | 36.16 | 485K | 117K | SEC |
| 2026-03-02 | 03-04 | McGuire Annie | SVP, General Counsel | F 繳稅扣股 | 6.9K | 36.01 | 249K | 101K | SEC |
| 2026-03-02 | 03-04 | Stapley Marc | Chief Executive Officer | F 繳稅扣股 | 19.5K | 36.01 | 701K | 403K | SEC |
| 2026-03-02 | 03-04 | Leite John | Chief Commercial Officer-CLIA | F 繳稅扣股 | 7.5K | 36.01 | 271K | 113K | SEC |
| 2026-02-26 | 03-02 | Chambers Rebecca | Chief Financial Officer | A 獲配股票 | 59.3K | – | – | 169K | SEC |
| 2026-02-26 | 03-02 | Leite John | Chief Commercial Officer-CLIA | F 繳稅扣股 | 8.9K | 38.75 | 345K | 120K | SEC |
| 2026-02-26 | 03-02 | Febbo Phillip G. | Chief Scientific & Med Officer | A 獲配股票 | 71.8K | – | – | 161K | SEC |
| 2026-02-26 | 03-02 | McGuire Annie | SVP, General Counsel | F 繳稅扣股 | 10.9K | 38.75 | 421K | 108K | SEC |
| 2026-02-26 | 03-02 | McGuire Annie | SVP, General Counsel | A 獲配股票 | 51.0K | – | – | 119K | SEC |
| 2026-02-26 | 03-02 | Chambers Rebecca | Chief Financial Officer | F 繳稅扣股 | 12.0K | 38.75 | 467K | 157K | SEC |
| 2026-02-26 | 03-02 | Stapley Marc | Chief Executive Officer | F 繳稅扣股 | 35.8K | 38.75 | 1.4M | 423K | SEC |
| 2026-02-26 | 03-02 | Febbo Phillip G. | Chief Scientific & Med Officer | F 繳稅扣股 | 24.5K | 38.75 | 949K | 137K | SEC |
| 2026-02-26 | 03-02 | Stapley Marc | Chief Executive Officer | A 獲配股票 | 139K | – | – | 458K | SEC |
| 2026-02-26 | 03-02 | Leite John | Chief Commercial Officer-CLIA | A 獲配股票 | 47.1K | – | – | 129K | SEC |
| 2025-12-16 | 12-17 | McGuire Annie | SVP, General Counsel | S 公開市場賣出(10b5-1) | 100 | 43.68 | 4K | 67.8K | SEC |
| 2025-12-16 | 12-17 | McGuire Annie | SVP, General Counsel | S 公開市場賣出(10b5-1) | 10.6K | 43.13 | 459K | 67.9K | SEC |
| 2025-12-05 | 12-08 | EASTHAM KARIN | Director | M 選擇權執行 | 10.0K | 7.94 | 79K | 23.6K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 13.5M | 792M | 新進 | 新進 |
| FMR LLC | 7.7M | 452M | 新進 | 新進 |
| Artisan Partners Limited Partnership | 5.5M | 325M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.7M | 277M | 新進 | 新進 |
| STATE STREET CORP | 4.7M | 276M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6M | 211M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 2.8M | 166M | 新進 | 新進 |
| FIRST TRUST ADVISORS LP | 2.5M | 147M | 新進 | 新進 |
| 方舟(伍德) ARK Investment Management LLC | 2.3M | 135M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.3M | 134M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1M | 124M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 1.6M | 96.5M | 新進 | 新進 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.5M | 88.7M | 新進 | 新進 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.4M | 84.1M | 新進 | 新進 |
| MORGAN STANLEY | 1.2M | 70.0M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 1.1M | 64.7M | 新進 | 新進 |
| Driehaus Capital Management LLC | 1.0M | 61.4M | 新進 | 新進 |
| NORTHERN TRUST CORP | 996K | 58.5M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 940K | 55.2M | 新進 | 新進 |
| OBERWEIS ASSET MANAGEMENT INC/ | 878K | 51.5M | 新進 | 新進 |
| Legal & General Group Plc | 858K | 50.4M | 新進 | 新進 |
| Sumitomo Mitsui Trust Group, Inc. | 769K | 45.2M | 新進 | 新進 |
| Amova Asset Management Americas, Inc. | 769K | 45.1M | 新進 | 新進 |
| Point72(柯恩) Point72 Asset Management, L.P. | 738K | 43.3M | 新進 | 新進 |
| Fisher Asset Management, LLC | 701K | 41.1M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 370 +36 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 370 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 89.2M · 100.0% |
| 合計季末市值 | 5.1B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 8.1M |
|---|---|
| 與上期比 | +19.0% |
| 佔流通股數 | 10.05% |
| 日均成交量 | 1.4M |
| 回補天數 | 5.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 8.1M | +19.0% | 10.05% | 1.4M | 5.8 |
| 2026-08-14 | 6.8M | -1.0% | 8.45% | 1.2M | 5.6 |
| 2026-07-31 | 6.9M | +2.8% | 8.53% | 1.4M | 4.8 |
| 2026-07-15 | 6.7M | -0.6% | 8.30% | 989K | 6.8 |
| 2026-06-30 | 6.7M | -20.9% | 8.36% | 1.8M | 3.8 |
| 2026-06-15 | 8.5M | +15.5% | 10.56% | 1.3M | 6.5 |
| 2026-05-29 | 7.4M | -14.4% | 9.15% | 1.1M | 6.5 |
| 2026-05-15 | 8.6M | +25.0% | 10.69% | 1.2M | 7.2 |
| 2026-04-30 | 6.9M | +6.5% | 8.55% | 745K | 9.2 |
| 2026-04-15 | 6.5M | +2.0% | 8.02% | 631K | 10.2 |
| 2026-03-31 | 6.3M | +17.6% | 7.87% | 1.1M | 5.6 |
| 2026-03-13 | 5.4M | -2.1% | 6.69% | 972K | 5.5 |
| 2026-02-27 | 5.5M | -9.3% | 6.83% | 829K | 6.6 |
| 2026-02-13 | 6.1M | +7.4% | 7.53% | 927K | 6.5 |
| 2026-01-30 | 5.6M | +8.8% | 7.01% | 817K | 6.9 |
| 2026-01-15 | 5.2M | +3.8% | 6.44% | 739K | 7.0 |
| 2025-12-31 | 5.0M | -5.0% | 6.21% | 616K | 8.1 |
| 2025-12-15 | 5.3M | -7.9% | 6.54% | 905K | 5.8 |
| 2025-11-28 | 5.7M | +4.7% | 7.10% | 1.1M | 5.3 |
| 2025-11-14 | 5.5M | -9.8% | 6.78% | 1.3M | 4.1 |
| 2025-10-31 | 6.0M | -10.1% | 7.52% | 686K | 8.8 |
| 2025-10-15 | 6.7M | -8.3% | 8.36% | 813K | 8.3 |
| 2025-09-30 | 7.3M | -19.7% | 9.12% | 998K | 7.4 |
| 2025-09-15 | 9.1M | +13.5% | 11.35% | 985K | 9.3 |
| 2025-08-29 | 8.0M | -1.4% | 10.00% | 915K | 8.8 |
| 2025-08-15 | 8.2M | -10.1% | 10.15% | 1.7M | 4.8 |